Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Waiting to Exhale Respiratory Disorders 1 A quick review • Upper airway – To larynx – Warms, humidifies, cleans – Cilia – Turbinates – Cribiform plate 2 Review, continued • Lower airway – Below larynx – Trachea – Bronchi – Alveoli – Surfactant 3 Lower airway, cont. • Lungs – Lobes – Visceral pleura – Parietal pleura 4 Review, continued • Ventilation – Inspiration – Expiration • Respiration-Tidal Volume – 500ml • Inspiratory Reserve Volume – 3000ml • Expiratory reserve volume – 1500ml • Residual volume – 1200ml • Dead air space – 150ml • Minute volume – TV x RR 5 What controls our breathing? • Medulla – 12-20/min • Transmitted through phrenic and intercostal nerves • Can be modified by – Cerebral cortex – Hypothalamus – Brainstem (pons) 6 What controls our breathing, cont. 7 More stuff • PCO2 increase = increased PCO2 in CSF = decreased pH Respiratory patterns Cheyne-Stokes Kussmaul’s Central neurogenic hyperventilation Ataxic (Biot’s) Apneustic 8 Respiratory Disorders • Incidence - 28% of all EMS C/C • Morbidity/Mortality - >200,000 deaths/yr. 9 Risk Factors Genetic predisposition Asthma COPD Carcinomas 10 Case Presentation One 11 12 Entering the bathroom the EMTs find: 13 14 The Patient Is: 15 16 17 18 19 20 • 1. What is her differential diagnosis? • 2. What treatment might you provide for this patient? Why? 21 Signs of life-threatening respiratory distress in adults • Altered mental status • Severe cyanosis • Absent breath sounds • Audible stridor • 1-2 word dyspnea • Tachycardia > 130/min. • Pallor and diaphoresis • Retractions/accessor y muscle use 22 COPD • Emphysema • Chronic Bronchitis • Asthma 23 Case Presentation Two • 24 25 You note the following: 26 27 28 • What is his differential diagnosis? • What treatment might you provide him? • Why? 29 Emphysema • Irreversible airway obstruction • Diffusion defect also exists because of blebs - prone to collapse - pt. exhales with pursed lips • Almost always associated with cigarette smoking or environmental toxins 30 Pathophysiology • Destruction of alveolar walls distal to terminal bronchioles. • More common in men • Walls of alveoli gradually distruct, = alveolar membrane surface area. Results in ratio of air to lung tissue. • Pulmonary capillaries , = resistance to pulmonary blood flow. • Causes pulmonary hypertension, leads to RHF, then Cor Pulmonale 31 Pathophys. . (Cont ) • Bronchiole walls weaken, lungs lose elasticity, air is trapped. Residual volume, but vital capacity relatively normal. • PaO2 , = RBC, polycythemia. • PaCO2 , is chronically elevated. The body depends on hypoxic drive. • Pt’s are more susceptible to pneumonia, dysrhythmias. • Meds; bronchodilators, corticosteroids, O2. 32 Assessment • • • • Altered mentation 1-2 word dyspnea Absent breath sounds c/c Dyspnea, morning cough, nocturnal dyspnea, wheezing 33 • History – Personal or family hx of allergies/asthma – Acute exposure to pulmonary irritant – Previous similar expisodes – Recent wt. loss, exertional dyspnea – Usually > 20 pack/year/history 34 Exam • Wheezing • Retractions and/or accessory muscle use • Barrel chest • Prolonged expiratory phase • Rapid resting respiratory rate • • • • Thin Pink puffers Clubbing of fingers Diminished breath sounds • JVD, hepatic congestion, peripheral edema 35 Management • • • • • • • Pulse oximeter Intubation prn Assisted ventilation prn High flow oxygen IV therapy with fluids Albuterol, or Albuterol/Atrovent neb Transport considerations 36 Chronic Bronchitis • Productive cough for at least 3 months for two or more consecutive years • An increase in mucous-secreting cells • Characterized by large quantity of sputum • Chronic smoker • Alveoli not severely affected - diffusion nl. • gas exchange = hypoxia & hypercarbia • May increase RBC = polycythemia • paCO2 = irritability, h/a, personality changes, intellect. • paCO2 = pulmonary hypertension & eventually cor pulmonale. 37 Assessment • Hx heavy cigarette smoking • Frequent resp. infections • Productive cough • Overweight, possibly cyanotic blue bloaters • Rhonchi on auscultation - mucous plugs • S/S RHF; JVD, edema, hepatic congestion 38 Management • Pulse oximetry • Oxygen - low flow if possible • Albuterol inhaler • Constantly monitor • Position - seated • IV TKO 39 Case Presentation Three 40 41 42 43 44 You find the following: 45 46 47 • What is your differential diagnosis? • What treatment would you offer this patient and why? 48 Asthma • Reversible obstruction caused by combination of smooth muscle spasm, mucous, edema • Exacerbating factors - intrinsic in children, extrinsic in adults • Status asthmaticus - prolonged exacerbation doesn’t respond to therapy • Significant increase in deaths in last decade45 years or older - black 2x higher • 50% are prehospital deaths. 49 Pathophysiology • A chronic inflammatory airway disorder. • Triggers vary - allergens, cold air, exercise, food, irritants, medications. • A two-phase reaction • Phase one – Histamine release - bronchial contraction, leakage of fluid from peribronchial capillaries = bronchoconstriction, bronchial edema. – Often resolves in 1 - 2 hours 50 Pathophysiology (cont.) • Phase two – 6-8 hours after exposure, inflammation of bronchioles - eosinophils, neutrophils, lymphocytes invade respiratory mucosa; = additional edema, swelling. – Doesn’t typically respond to inhalers; often requires corticosteriods. • Inflammation usually begins days/weeks before attack. 51 Assessment • Dyspnea, 1-2 word dyspnea • Persistent, nonproductive cough • Wheezing • Hyperinflation of chest • Tachypnea, accessory muscle use • Pulsus paradoxis – 10-15 mm bp drop during insp vs exp • Agitated, anxious • Decreased oxygen saturation • Tachycardia • Hx of allergies • Auto PEEP • Potential tensions (bilateral) 52 Management • • • • • • • • • Check home meds Determine onset of sx & what pt. has taken Check vitals carefully - resp. x 30 sec. High flow oxygen IV with fluids ECG Inhalers Consider epinephrine 1:1,000 SQ, 0.3-0.5 mg Consider Solu-Medrol, 1 –2 mg/kg IVP, max 125 mg 53 Status Asthmaticus • Severe, prolonged asthma attack not responsive to tx. • Greatly distended chest • Absent breath sounds • Pt. exhausted, dehydrated, acidotic. • Treat aggressively if obtunded, profuse diaphoresis, floppy – Intubate (poss RSI) • Transport immediately 54 Case Presentation Four 55 56 57 58 Your exam reveals the following: 59 • What is his differential diagnosis? • What treatment would you offer this patient? Why? 60 Pneumonia • 5th leading cause of death in US • Risk factors – – – – Cigarette smoking Alcoholism Cold exposure Extremes of age • Pathophysiology – A common respiratory disease caused by infectious agent. bacterial and viral pneumonia most frequent. – May cause atelectasis – May become systemic = sepsis 61 Assessment • Typical – Acute onset of fever and chills – Cough productive with yellow/green sputum (bad breath!) – May have pleuritic chest pain – Pulmonary consolidation on auscultation – Rales – Egophony (strange lung sounds) • Atypical – Non-productive cough – H/A – Fatigue 62 Management • • • • • • Position Oxygen Consider breathing tx. IV with fluids Cool if febrile Elderly, over 65 years – Significant co-morbidity – Inability to take meds – Support complications 63 Case Presentation Five 64 On physical exam: 65 66 • What is your differential diagnosis? • What treatment would you offer this patient? Why? 67 Hyperventilation Syndrome • Multiple causes – Hypoxia – High altitude – Pulmonary disease – Pneumonia – Interstitial pneumonitis, fibrosis, edema – Pulmonary emboli – Bronchial asthma – Congestive heart failure – Hypotension – Metabolic disorder – Acidosis 68 Hyperventilation Syndrome • Causes, cont. – – – – – – – – – – – – (cont) Hepatic failure Neurologic disorders Psychogenic or anxiety hypertension Central nervous system infection, tumors Drug-induced Salicylate Methylxanthine derivatives Beta-adrenergic agonists Progesterone Fever,sepsis Pain Pregnancy 69 Assessment • Chief complaint – Dyspnea – Chest pain – Other sx based on etiology – Carpopedal spasm – Tachypnea with high minute volume 70 Management • Depends on cause of syndrome • Oxygen based on sx and pulse oximetry • Consider coached ventilation 71 Upper Respiratory Infection (URI) • One of most common c/c • Usually viral • Bacterial infections – Group A streptococcus • Strep throat • Sinusitis • Middle ear infections • Most URI’s self-limiting 72 URI continued • S/S – Fever – Chills – Myalgias – Fatugue • Tx – Supportive – Acetaminophen, ibuprofen, liquids 73 URI, cont. • If pediatric, beware of possibility of epiglotitis • If PMH; Asthma or COPD, condition may worsen – Consider nebulized meds 74 Lung CA • Most caused by cigarette smoking • 4 major types – Adenocarcinoma – most common • Origin; mucus-producing cells – Small cell carcinoma – Epidermoid carcinoma – Large cell carcinoma • Origin; bronchial tissues • Most patients die w/in one year 75 Lung CA, continued • General Assessment; • Advanced disease – – – – – Altered mentation 1-2 word sentences Cyanosis Hemoptysis Hypoxia – – – – Profound weight loss Cachexia Malnutrition Crackles, rhonchi, wheezes – Diminished breath sounds – Venous distention in arms and neck 76 • Localized disease – Cough, dyspnea, hoarseness, vague chest pain, hemoptysis • Local invasion – Pain on swallowing (dysphagia) – Weakness, numbness in arm – Shoulder pain • Metastatic spread – Headache, seizures, bone pain, abdominal pain, nausea, mailaise 77 Tx for Lung CA • • • • • • Oxygen prn Support ventilations Intubate prn DNR / Advanced directive? IV Nubulized meds 78 Toxic inhalation • Consider if pt dyspneac • Causes – Superheated air – Products of combustion – Chemical irritants – Steam inhalation 79 Inhalation injury, cont. • Medic safety – Ammonia (ammonium hydroxide) – Nitrogen oxide (nitric acid) – Sulfer dioxide (sulfurous acid) – Sulfur trioxide (sulfuric acid) – Chlorine (hydrochloric acid) 80 • Assessment – Enclosed space? – Loss of consciousness? – Mouth, face, throat, nares – Auscultate chest – Laryngeal edema • Hoarseness, brassy cough, stridor • Management – Maintain airway – High-flow humidified oxygen – IV 81 Carbon Monoxide inhalation • Incomplete burning of fossel fuels, other carbon-containing compounds • Automobile exhaust, home-heating devices most common causes • CO has >200x affinity for hemoglobin – Cellular hypoxia • Also binds to iron-containing enzymes – Increased cellular acidosis 82 CO, continued • Assessment – Source, length of exposure? Closed vs open space? • S/S – H/A, N/V, confusion, agitation, loss of coordination, chest pain, loss of consciousness, seizures – Cyanosis – Cherry red (very late) 83 CO, continued • Management – SAFETY – Maintain airway – High flow oxygen (NRB vs assist – Hyperbaric oxygen therapy 84 Pulmonary Embolus • • • • Thrombus Ventilation perfusion mismatch 50,000 deaths in US annually Conditions that predispose to PE – – – – – – Recent surgery Long-bone fracture Bedridden Long flights/truck drivers Pregnancy Cancer, infections, thrombophlebitis, Af, sickle cell enemia – BCP 85 PE, cont • Assessment – Sudden onset SOB, Hypoxic – Pleuritic chest pain – Non-productive cough – History – Labored breathing, tachypnea, tachycardia – RHF – DVT present 86 PE, cont • • • • • • • Management ABC Airway High flow oxygen ET? IV – flow rate? Heparin gtt? TPA? 87 Spontaneous pneumothorax • Common- high recurrent rate – 5:1 male to female – Tall, thin – Smoking history – 20-40 years old – COPD = increased risk • Ventilation perfusion mismatch if > 20% 88 Spont. Pneumothorax, cont. • Assessment – Sudden onset sharp chest or shoulder pain – Coughing/lifting – Dyspnea – Decreased breath sounds at apex – Hyper resonance – Sub-cutaneous emphysema – Tachypnea, diaphoresis, pallor 89 Spont. Pneumothorax, cont. • Management – Supplemental oxygen – If sx increase, consider needle decompression – Position of comfort 90